Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOX1 | Q06278 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 7/20 | 0.36 |
| ▸ | TMEM97 | Q5BJF2 | 5/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.35 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.35 |
| ▸ | RAD52 | P43351 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5463216 | 0.93 | AOX1 (0.44) | AOX1HDAC1HDAC6PIK3CDCA12 | |
| SCHEMBL14428402 | 0.93 | AOX1 (0.40) | AOX1HDAC1HDAC6PIK3CDHTT | |
| SCHEMBL5452794 | 0.92 | HDAC1 (0.49) | AOX1HDAC1HDAC6HTTCA12 | |
| SCHEMBL14428378 | 0.91 | RAD52 (0.43) | HTTCA12CA1CA2CA9 | |
| SCHEMBL5467865 | 0.90 | RAD52 (0.42) | AOX1HDAC1HDAC6HTTCA12 | |
| SCHEMBL5463093 | 0.87 | HDAC1 (0.46) | AOX1HDAC1HDAC6HTTAPP | |
| SCHEMBL5455149 | 0.87 | HDAC1 (0.46) | AOX1HDAC1HDAC6HTTAPP | |
| SCHEMBL5461314 | 0.87 | CA12 (0.39) | AOX1HDAC1HDAC6PIK3CDHTT | |
| SCHEMBL5452770 | 0.86 | MEN1 (0.43) | CA12CA1CA2CA9SIGMAR1 | |
| SCHEMBL5455213 | 0.85 | AOX1 (0.49) | AOX1HDAC1HDAC6HTTCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070191372-A1 | Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy | AUCKLAND UNISERVICES LIMITED (NZ) | 2007-08-16 | — | — | US | disclosed |
| US-20070191372-A1 | Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy | AUCKLAND UNISERVICES LIMITED (NZ) | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191372-A1 | Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy | HIF1AN, HIF1A, HYOU1 | AOX1 404/4885HDAC1 1200/4885HDAC6 2421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.